TY - JOUR T1 - Purinergic Receptor Expression and Cellular Responses to Purinergic Agonists in Human Prostate Cancer Cells JF - Anticancer Research JO - Anticancer Res SP - 529 LP - 537 VL - 37 IS - 2 AU - KORNKAMON LERTSUWAN AU - WACHEN PETERS AU - LINDSAY JOHNSON AU - JOMNARONG LERTSUWAN AU - IRENE MARWA AU - ROBERT A. SIKES Y1 - 2017/02/01 UR - http://ar.iiarjournals.org/content/37/2/529.abstract N2 - Background: Anticancer activity of extracellular nucleotides has been investigated in many types of cancer. Herein, the effects of extracellular nucleotides and the receptor profile for these nucleotides on prostate cancer (PCa) were elaborated. Materials and Methods: PCa cell lines representing different stages of PCa were used. The effects of ATP and adenosine on PCa growth and migration on different extracellular matrix proteins were examined by MTT and wound-healing assays. Purinergic receptor profiling was carried out by reverse transcription-polymerase chain reaction (RT-PCR). Results: A growth-inhibitory effect of ATP and adenosine was observed on all PCa cell lines tested. Several ATP-recognized P2 receptors and adenosine receptors were commonly expressed in PCa cell lines. Neither ATP nor adenosine had any significant effect on PCa migration. Conclusion: ATP and adenosine had an antiproliferative effect on PCa cells without affecting their motility, indicating their potential as a novel therapy for PCa. ER -